Association of GLP-1 receptor agonist use with long-term outcomes in patients with opioid use disorder
{{output}}
Opioid use disorder (OUD) is a major public health challenge with high overdose mortality and healthcare utilization. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiometabolic and neurobiological benefits, including modulation of reward pathwa... ...
